PHT

1 known investors

Clario develops clinical trial endpoint technologies and software for drug development and patient safety monitoring. The platform serves pharmaceutical sponsors, contract research organizations, and clinical trial sites globally, offering cardiac safety, patient-reported outcomes, medical imaging, respiratory, and AI-powered solutions across site-based, hybrid, and decentralized trial models.

AI & Machine LearningHealthtechMedical Devices